| Li, Li |
NCT04146155: Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease |
|
|
| Recruiting | 4 | 200 | RoW | Liraglutide+standard-of-care treatment, Victoza, standard-of-care treatment | Second Affiliated Hospital, School of Medicine, Zhejiang University | Type 2 Diabetes, Peripheral Vascular Disorder Due to Diabetes Mellitus | 12/21 | 12/21 | | |
NCT04713358: Effect of Nalmefene on the Quality of Resuscitation in Patients Under General Anesthesia |
|
|
| Recruiting | 4 | 520 | RoW | Nalmefene, normal Saline | RenJi Hospital, Shanghai Tong Ren Hospital, First Affiliated Hospital of Guangxi Medical University, The First Affiliated Hospital of Zhengzhou University | Resuscitation | 12/23 | 12/23 | | |
ERASE, NCT06093191: Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis |
|
|
| Recruiting | 4 | 364 | RoW | Tobramycin Inhalant Product, Inhaled antibiotics, Ciprofloxacin 750 MG, Oral antibiotics, Oral ciprofloxacin placebo, Natural saline inhalation, Inhaled saline | Shanghai Pulmonary Hospital, Shanghai, China | Bronchiectasis Adult, Pseudomonas Aeruginosa Infection | 10/25 | 12/25 | | |
NCT05622890: A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer |
|
|
| Recruiting | 3 | 35 | RoW | Mirvetuximab Soravtansine, IMGN853, MIRV | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer | 04/23 | 12/23 | | |
NCT06697522: Study of Atropine Sulfate Eye Drops(0.01%) in Treating Near-work-induced Transient Myopia in Children |
|
|
| Completed | 3 | 148 | RoW | Atropine Sulfate, Investigational product, Placebo, Blank Solvent | Ocumension Therapeutics (Suzhou) Co., Ltd, Beijing Children's Hospital | Myopia | 10/23 | 03/24 | | |
NCT05793892: Efficacy and Safety of Lidocaine and Tetracaine Cream for Facial Laser Aesthetics in Chinese Adults |
|
|
| Completed | 3 | 286 | RoW | Lidocaine tetracaine cream, test drug:CU-30101, control drug:Pliaglis | Cutia Therapeutics（Wuxi）Co.,Ltd | Analgesia | 08/23 | 10/23 | | |
QWINT-2, NCT05362058: A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time |
|
|
| Completed | 3 | 928 | Europe, Canada, Japan, US, RoW | Insulin Efsitora Alfa, LY3209590 and Basal Insulin-FC, Insulin Degludec | Eli Lilly and Company | Diabetes, Type 2 Diabetes | 04/24 | 04/24 | | |
ATTAIN-OSA, NCT06649045: A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight |
|
|
| Recruiting | 3 | 600 | Europe, Japan, US, RoW | Orforglipron, LY3502970, Placebo | Eli Lilly and Company | OSA, Overweight or Obesity | 11/26 | 01/27 | | |
NCT06717152: Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease |
|
|
| Recruiting | 3 | 400 | RoW | SJP-0132, Placebo | Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd., Senju Pharmaceutical Co., Ltd. | Dry Eye | 07/25 | 08/25 | | |
ATTAIN-1, NCT05869903: A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities |
|
|
| Active, not recruiting | 3 | 3000 | Europe, Japan, US, RoW | Orforglipron, LY3502970, Placebo | Eli Lilly and Company | Obesity, Overweight, Overweight or Obesity | 07/25 | 07/27 | | |
| Active, not recruiting | 3 | 2300 | Europe, Canada, US, RoW | Retatrutide, LY3437943, Placebo | Eli Lilly and Company | Obesity, Overweight, Osteoarthritis, Knee, Obstructive Sleep Apnea | 04/26 | 05/26 | | |
Keypoint-1, NCT05302011: Neoadjuvant Pembrolizumab Plus Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma |
|
|
| Completed | 2 | 28 | RoW | Pembrolizumab, Carboplatin or Cisplatin, chemotherapy, Docetaxel | Peking Union Medical College Hospital | Esophageal Squamous Cell Carcinoma | 03/23 | 06/23 | | |
NCT06161272: Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi |
|
|
| Not yet recruiting | 2 | 80 | RoW | Fluzoparib, Fluzoparib+Apatinib | Guangxi Medical University | Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, Primary Peritoneal Carcinoma, Fallopian Tube Cancer | 03/25 | 01/26 | | |
NCT06176235: Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia |
|
|
| Recruiting | 2 | 132 | RoW | Teriflunomide, AUBAGIO, Dexamethasone | Peking University People's Hospital, Beijing Luhe Hospital, Chinese PLA General Hospital, Navy General Hospital, Beijing, Beijing Hospital, Beijing Friendship Hospital, Peking University First Hospital, Peking University Third Hospital, China-Japan Friendship Hospital, Beijing Tsinghua Changgeng Hospital | Immune Thrombocytopenia | 12/24 | 05/25 | | |
NCT05932524: Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune Thrombocytopenia |
|
|
| Recruiting | 2 | 132 | RoW | Baricitinib 2 MG, Olumiant, Dexamethasone, HD-DXM | Peking University People's Hospital, Beijing Luhe Hospital, Chinese PLA General Hospital, Navy General Hospital, Beijing, Beijing Hospital, Beijing Friendship Hospital, Peking University First Hospital, Peking University Third Hospital, China-Japan Friendship Hospital, Beijing Tsinghua Changgeng Hospital | Immune Thrombocytopenia | 06/24 | 06/25 | | |
NCT05852847: Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia |
|
|
| Recruiting | 2 | 216 | RoW | Baricitinib 2 MG [Olumiant], Olumiant, Danazol | Peking University People's Hospital, Beijing Luhe Hospital, Chinese PLA General Hospital, Navy General Hospital, Beijing, Beijing Hospital, Beijing Friendship Hospital, Peking University First Hospital, Peking University Third Hospital, China-Japan Friendship Hospital, Beijing Tsinghua Changgeng Hospital | Immune Thrombocytopenia | 11/24 | 05/25 | | |
CRTOG2401, NCT06714708: Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC |
|
|
| Recruiting | 2 | 86 | RoW | Experimental, Active comparator | Anhui Provincial Cancer Hospital | NSCLC, Neoadjuvant Immunotherapy, Low Dose Radiotherapy, Sintilimab | 12/26 | 06/27 | | |
| Recruiting | 1/2 | 725 | RoW | JSKN003 | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Advanced Solid Tumor | 12/24 | 12/26 | | |
|
| Not yet recruiting | 1/2 | 190 | US | a bundled intervention, control group | University of Alabama at Birmingham, National Institute on Drug Abuse (NIDA) | Opioid Use Disorder, Opioid Overdose | 11/30 | 11/30 | | |
OPAL-1, NCT05970497: A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors |
|
|
| Recruiting | 1/2 | 240 | US | KB707, Opdualag, KEYTRUDA ®( Pembrolizumab) | Krystal Biotech, Inc. | Cancer, Melanoma Stage III, Melanoma Stage IV, Cutaneous Melanoma | 07/27 | 07/27 | | |
NCT04977193: A Study to Evaluate the Safety and Efficacy of ly011 Cell Injection in the Treatment of Advanced Gastric Adenocarcinoma |
|
|
| Recruiting | 1 | 18 | RoW | LY011 | Shanghai Longyao Biotechnology Inc., Ltd., The Affiliated Hospital of Xuzhou Medical University | Advanced Gastric Adenocarcinoma | 05/23 | 11/24 | | |
TQB2858-Ⅰ-06, NCT05068921: A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignancy |
|
|
| Recruiting | 1 | 40 | RoW | TQB2858 injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Cervical Cancer | 05/23 | 07/23 | | |
NCT06678581: SAD,MAD and Food Effect Study of SAP-001 Tablets in Chinese Subjects |
|
|
| Completed | 1 | 70 | RoW | SAP-001, SAP-001 tablet, Placebo, placebo tablet | Shanton Pharma Co., Ltd. | Gout, Hyperuricemia | 12/23 | 01/24 | | |
DEVIF-I, NCT06230822: Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary Fibrosis (IPF) |
|
|
| Recruiting | 1 | 9 | RoW | VUM02 Injection, Human Umbilical Cord Tissue-derived Mesenchymal Stem Cells Injection | Wuhan Optics Valley Vcanbiopharma Co., Ltd. | Idiopathic Pulmonary Fibrosis | 01/25 | 12/26 | | |
OASIS, NCT06063317: A Study of OnCARlytics (CF33-CD19) in Combination with Blinatumomab in Adults with Advanced or Metastatic Solid Tumors |
|
|
| Recruiting | 1 | 33 | US | CF33-CD19 IT, CF33-CD19 IV, Blinatumomab, Blincyto | Imugene Limited | Solid Tumor, Adult | 06/27 | 05/29 | | |
NCT06104215: BGT007H Cells for the Treatment of Refractory Digestive System Tumors |
|
|
| Recruiting | 1 | 14 | RoW | BGT007H Injection | The Affiliated Hospital of Xuzhou Medical University, Guangzhou Bioresette Biomedical Technology Co., Ltd. | Digestive Tract Cancer | 10/26 | 10/27 | | |
NCT06104241: BGT007 Cells for the Treatment of Refractory Digestive System Tumors |
|
|
| Recruiting | 1 | 14 | RoW | BGT007 Injection | The Affiliated Hospital of Xuzhou Medical University, Guangzhou Bioresette Biomedical Technology Co., Ltd. | Gastrointestinal Cancer | 10/26 | 10/27 | | |
Solitaire, NCT04692402: Feasibility Trial Evaluating Efficacy and Safety of â„¢ Thrombus Retrieval Device in the Management of Refractory Thrombus in Patients With Acute Coronary Syndrome |
|
|
| Recruiting | N/A | 51 | RoW | Solitaireâ„¢ thrombus retrieval device | Paul Ong | Refractory Thrombus in Patients With Acute Coronary Syndrome | 06/22 | 09/22 | | |
NCT05469152: Detachable String Magnetically Controlled Capsule Endoscopy for Follow-up of Patients With Esophageal Diseases |
|
|
| Recruiting | N/A | 310 | RoW | ds-MCE and EGD | Changhai Hospital, Ruijin Hospital, Shanghai Zhongshan Hospital, XuHui District Central Hospital, Yangpu District Central Hospital Affiliated to Tongji University, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 6th People's Hospital | Esophageal Diseases | 09/22 | 09/22 | | |
NCT05273840: Effect of Nutritional Supplements on Clinical Outcomes in Patients With Prediabetes and Obesity |
|
|
| Recruiting | N/A | 100 | RoW | Ivital Control, Produced by Fresenius Kabi, Chocolate flavor, Product specifications: 460g (46g*10), lifestyle intervention | Ningbo No. 1 Hospital | PreDiabetes, Obesity | 10/22 | 11/22 | | |
NCT03748563: Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis |
|
|
| Completed | N/A | 607 | RoW | ds-MCE and EGD | Changhai Hospital, Ruijin Hospital, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai East Hospital of Tongji University, Yangpu District Central Hospital Affiliated to Tongji University, Zhujiang Hospital, Qilu Hospital of Shandong University, The Third Xiangya Hospital of Central South University, First Affiliated Hospital Xi'an Jiaotong University, Wuhan Union Hospital, China, The Fifth Affiliated Hospital of Zunyi Medical College, The First Affiliated Hospital of Zhejiang Chinese Medical University, Shanghai Pudong New Area Gongli Hospital | Liver Cirrhosis, Portal Hypertension, Esophageal Varices, Gastric Varix | 01/23 | 03/23 | | |
| Completed | N/A | 120 | RoW | lifestyle intervention | Ningbo No. 1 Hospital, Peking University | Diabetes Mellitus, Type 2, Overweight or Obesity | 06/23 | 07/23 | | |
NCT06493669: Study on the Correlation Between Treg Immune Cells on the Muscle Content and Cognitive Functions of the Elderly |
|
|
| Recruiting | N/A | 100 | RoW | Cognitive assessment | Fifth Affiliated Hospital, Sun Yat-Sen University | Cognitive Disorder Patients and Cognitive Assessment | 12/24 | 12/24 | | |
NCT06371313: Endocrine, Metabolic and Inflammatory Characteristics of Offspring of Mothers With PCOS Hyperandrogenism |
|
|
| Completed | N/A | 42 | RoW | | Guangdong Women and Children Hospital | PCOS | 03/24 | 03/24 | | |
NCT05389254: Association Between Time in Range and In-hospital Outcomes in Type 2 Diabetic Patients With Acute Coronary Syndrome |
|
|
| Not yet recruiting | N/A | 100 | RoW | continuous glucose monitoring system, capillary blood glucose monitoring | Ningbo No. 1 Hospital | Type 2 Diabetes Mellitus, Acute Coronary Syndrome | 06/23 | 12/23 | | |
| Recruiting | N/A | 300 | RoW | radiomic of chest CT | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Early Prediction for Sepsis Induced Acute Lung Injury | 08/23 | 12/23 | | |
NCT05455099: A Multicenter Study of Ultrafast Pulse Wave Velocity in Obese Chinese Han Adults |
|
|
| Recruiting | N/A | 2400 | RoW | Carotid ultrasound examination 1, Carotid ultrasound examination 2 | First Hospital of China Medical University | Carotid Artery Diseases | 08/23 | 07/24 | | |
| Recruiting | N/A | 20 | US | Soluble Corn Fiber, Maltodextrin | Ochsner Health System | Rectal Cancer | 12/23 | 07/24 | | |
NCT05482191: Healthy Weight Management Project for Overweight and Obesity Children |
|
|
| Active, not recruiting | N/A | 300 | RoW | Lifestyle intervention | Ningbo No. 1 Hospital, Peking University | Obesity | 12/23 | 12/25 | | |
NCT05482165: Optimizing Intervention Effects in Children and Adolescents |
|
|
| Active, not recruiting | N/A | 1800 | RoW | Multi-faceted health promotion programme | Ningbo No. 1 Hospital, Peking University | Childhood Obesity | 12/23 | 12/25 | | |
NCT05872425: Efficacy and Safety of Dingkundan Combined With Combination Oral Contraceptives in the Treatment of PCOS |
|
|
| Completed | N/A | 120 | RoW | DingKunDan(GuangYuYuan), DingKunDan(GuangYuYuan): Z20059003, Drospirenone and Ethinylestradiol Tablets (Ⅱ): H20140972, Drospirenone and Ethinylestradiol Tablets (Ⅱ) | Guangdong Women and Children Hospital | PCOS | 04/24 | 04/24 | | |
NCT06256848: Effect of Myofascial Release on Dysphagia in Stroke Survivors |
|
|
| Recruiting | N/A | 80 | RoW | Rehabilitation treatment, Myofascial Release Therapy | Zeng Changhao, People's Hospital of Zhengzhou University | Dysphagia | 05/24 | 05/24 | | |
NCT06249516: Effect of Active Breathing Exercises in Stroke Patients With Respiratory Rhythm Disorder |
|
|
| Not yet recruiting | N/A | 80 | RoW | Rehabilitation training, Active Breathing Exercises | Zeng Changhao, People's Hospital of Zhengzhou University | Respiratory Rhythm Disorder | 06/24 | 06/24 | | |
NCT06427018: Expressions of Ezrin and Pip5k1α Proteins in Airway Smooth Muscle of Asthmatic Patients |
|
|
| Recruiting | N/A | 60 | RoW | No intervention. | Lei-Miao Yin, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 6th People's Hospital, Xiangya Hospital of Central South University, Baoshan Hospital, Shanghai University of Traditional Chinese Medicine | Asthma, Protein | 06/25 | 12/25 | | |
Al-MDS, NCT05974163: Development of an AI-based Emergency Imaging Multi-Disease Rapid Joint Screening System |
|
|
| Not yet recruiting | N/A | 10000 | RoW | radiomic of CT | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Emergency Medical Services, Critical Illness, Emergency Service, Hospital, Machine Learning, Diagnosis | 07/24 | 07/25 | | |
NCT06606509: The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM). |
|
|
| Not yet recruiting | N/A | 1000 | RoW | Continuous Glucose Monitoring System (GX-01S) | Nanjing First Hospital, Nanjing Medical University | Type1 Diabetes Mellitus | 10/26 | 06/27 | | |
| Not yet recruiting | N/A | 120 | NA | iSIPsmarter Program, Sugary Drink Program, Patient Education, Cancer Prevention Program | University of Virginia | Colorectal Neoplasms | 11/29 | 11/30 | | |
NCT06737848: The Comparison of Single Catheter and Double Catheter Adrenal Vein Sampling Methods Based on the Upper Limb Approach |
|
|
| Not yet recruiting | N/A | 70 | NA | Single catheter adrenal vein sampling, Double catheters adrenal vein sampling | Army Medical University, China | Primary Aldosteronism | 04/25 | 07/25 | | |
NCT05976529: A Multicenter, Observational Clinical Study of Dydrogesterone |
|
|
| Recruiting | N/A | 400 | RoW | | Guangdong Women and Children Hospital | Endometriosis, Endometriosis Ovary | 04/25 | 12/25 | | |
NCT05315492: Strengthening Community Addiction Services in Vietnam |
|
|
| Active, not recruiting | N/A | 1620 | RoW | Community Care Consortium (CCC) | University of California, Los Angeles | Addiction, Opioid | 09/25 | 07/26 | | |
| Su, Guanfang |
NCT05180526: Assessment of Safety , Clinical Efficacy with QLETLI in Non-infectious Uveitis (UV) |
|
|
| Active, not recruiting | 4 | 60 | RoW | QLETLI | Bio-Thera Solutions | Uveitis | 12/24 | 12/24 | | |
NCT06717152: Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease |
|
|
| Recruiting | 3 | 400 | RoW | SJP-0132, Placebo | Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd., Senju Pharmaceutical Co., Ltd. | Dry Eye | 07/25 | 08/25 | | |
| Su |
NCT06683651: A Study in Chinese Patients With Acquired Blepharoptosis |
|
|
| Recruiting | 3 | 180 | RoW | STN1013800 ophthalmic solution, STN1013800 ophthalmic solution Liquid Base, without STN1013800 | Santen Pharmaceutical Co., Ltd. | Blepharoptosis | 06/26 | 06/26 | | |
WU-KONG1, NCT03974022: Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer with EGFR or HER2 Mutation |
|
|
| Active, not recruiting | 1/2 | 315 | Europe, Canada, Japan, US, RoW | Sunvozertinib, DZD9008 | Dizal Pharmaceuticals | Non-Small Cell Lung Cancer | 07/24 | 07/25 | | |
| Xu, Xingxiang |
NCT05106335: A Study to Evaluate Camrelizumab Combined With Famitinib as Subsequent Therapy in Patients With Advanced NSCLC |
|
|
| Terminated | 3 | 1 | RoW | camrelizumab + famitinib, famitinib, docetaxel | Jiangsu HengRui Medicine Co., Ltd. | Advanced NSCLC | 05/22 | 05/22 | | |
PYRAMID-1, NCT04447118 / 2020-000951-11: Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy |
|
|
| Active, not recruiting | 3 | 151 | Europe, US, RoW | Pyrotinib, Irene, Docetaxel, Docetaxel injection | Jiangsu HengRui Medicine Co., Ltd. | Non-squamous NSCLC, HER2 Exon 20 Mutation | 06/23 | 10/23 | | |
NCT06198764: A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimethate Sodium for Injection |
|
|
| Recruiting | 3 | 80 | RoW | Colistimethate sodium for injection, Meropenem for Injection, Coly Mycin M Injectable Product | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Mental Health Issue | 03/26 | 03/26 | | |
NCT05042375: A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer |
|
|
| Recruiting | 3 | 450 | RoW | camrelizumab + famitinib, pembrolizumab, camrelizumab | Jiangsu HengRui Medicine Co., Ltd. | Non-small Cell Lung Cancer | 12/23 | 12/25 | | |
NCT05292196: A Phase II Clinical Trial of TQC3721 Suspension for Inhalation |
|
|
| Recruiting | 2 | 460 | RoW | TQC3721 suspension for inhalation, TQC3721 suspension placebo for inhalation | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Chronic Obstructive Pulmonary Disease (COPD) | 01/24 | 05/24 | | |
NCT05987371: A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease. |
|
|
| Recruiting | 2 | 72 | RoW | TQC3721 suspension for inhalation, TQC3721 matching placebo for inhalation, Salbutamol sulfate inhalation aerosol | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Chronic Obstructive Pulmonary Disease | 01/24 | 03/24 | | |
NCT05815862: Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer |
|
|
| Recruiting | 2 | 40 | RoW | AL2846 capsule | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Lung Cancer, Ovarian Cancer | 06/24 | 12/24 | | |
| Cai, Hanqing |
| Completed | 3 | 533 | RoW | Chiglitazar 32mg, Bilessglu, CS038, Chiglitazar 48mg, Placebo, Chiglitazar simulator, Metformin Hydrochloride, Glucophage | Chipscreen Biosciences, Ltd. | Type 2 Diabetes | 02/23 | 02/23 | | |
NCT05102149: Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus |
|
|
| Recruiting | 3 | 672 | RoW | PB-201, Vildagliptin, PB-201 matched placebo, Vildagliptin matched placebo | PegBio Co., Ltd. | Type 2 Diabetes Mellitus (T2DM) | 11/23 | 04/25 | | |
NCT06350890: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes |
|
|
| Active, not recruiting | 3 | 408 | RoW | HTD1801, berberine ursodeoxycholate, Placebo | HighTide Biopharma Pty Ltd | T2DM (Type 2 Diabetes Mellitus) | 03/25 | 09/25 | | |
Symphony2, NCT06353347: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin |
|
|
| Active, not recruiting | 3 | 551 | RoW | HTD1801, berberine ursodeoxycholate, Placebo | HighTide Biopharma Pty Ltd | Type 2 Diabetes Mellitus | 03/25 | 12/25 | | |
NCT06738979: A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects |
|
|
| Not yet recruiting | 3 | 408 | RoW | TQF3510 (Semaglutide Injection), Wegovy® | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Obesity | 07/26 | 08/26 | | |
NCT05278338: Efficacy and Safety of JMT103 in the Treatment of Postmenopausal Women With Osteoporosis |
|
|
| Recruiting | 2 | 200 | RoW | JMT103, Denosumab, Placebo | Shanghai JMT-Bio Inc. | Postmenopausal Osteoporosis | 12/23 | 03/24 | | |
NCT06481085: To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus |
|
|
| Not yet recruiting | 2 | 318 | RoW | HDM1002 50 mg, HDM1002, HDM1002 100 mg, HDM1002 200 mg, HDM1002 400 mg, HDM1002 200 mg BID, Placebo, Matching placebo for group A to group E | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Type 2 Diabetes | 04/25 | 04/25 | | |
NCT06606483: A Study to Evaluate the Efficacy and Safety of MDR-001 in Subjects Who Are Obesity or Overweight |
|
|
| Not yet recruiting | 2 | 300 | RoW | MDR-001, Placebo | MindRank AI Ltd | Obesity, Overweight and Obesity | 07/25 | 09/25 | | |
NCT06606509: The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM). |
|
|
| Not yet recruiting | N/A | 1000 | RoW | Continuous Glucose Monitoring System (GX-01S) | Nanjing First Hospital, Nanjing Medical University | Type1 Diabetes Mellitus | 10/26 | 06/27 | | |
